$203 Million is the total value of New Leaf Venture Partners, L.L.C.'s 21 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 4.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $86,785,000 | -18.1% | 1,289,521 | 0.0% | 42.77% | +11.5% | |
| RALLYBIO CORPORATION | $16,065,000 | -26.8% | 2,301,603 | 0.0% | 7.92% | -0.5% | ||
| HARP | HARPOON THERAPEUTICS INC | $15,689,000 | -34.2% | 3,156,699 | 0.0% | 7.73% | -10.5% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $15,071,000 | -36.5% | 1,553,661 | 0.0% | 7.43% | -13.6% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $11,213,000 | -5.1% | 1,209,571 | 0.0% | 5.53% | +29.1% | |
| DICE THERAPEUTICS INC | $10,650,000 | -24.4% | 556,693 | 0.0% | 5.25% | +2.8% | ||
| PASG | PASSAGE BIO | $7,744,000 | -51.2% | 2,497,922 | 0.0% | 3.82% | -33.6% | |
| APTX | APTINYX INC | $7,468,000 | -15.0% | 3,290,079 | 0.0% | 3.68% | +15.6% | |
| CMRX | CHIMERIX INC | $5,609,000 | -28.8% | 1,224,600 | 0.0% | 2.76% | -3.1% | |
| ALEC | ALECTOR INC | $4,839,000 | -31.0% | 339,569 | 0.0% | 2.38% | -6.1% | |
| SRRA | Sell | SIERRA ONCOLOGY INC | $4,023,000 | -54.8% | 125,511 | -69.4% | 1.98% | -38.5% |
| COGT | COGENT BIOSCIENCES INC. | $3,756,000 | -12.7% | 501,530 | 0.0% | 1.85% | +18.7% | |
| AMYT | AMRYT PHARMA PLC | $3,719,000 | -23.4% | 449,737 | 0.0% | 1.83% | +4.1% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $3,095,000 | -22.7% | 141,000 | 0.0% | 1.52% | +5.1% | |
| Sell | RENOVACOR CORPORATION | $2,851,000 | -46.9% | 672,288 | -3.6% | 1.40% | -27.8% | |
| ARAV | ARAVIVE INC | $1,827,000 | -11.9% | 946,423 | 0.0% | 0.90% | +19.8% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $726,000 | -23.6% | 117,242 | 0.0% | 0.36% | +4.1% | |
| XFOR | X4 PHARMACEUTICALS INC | $586,000 | -23.6% | 335,000 | 0.0% | 0.29% | +4.0% | |
| ITRM | ITERUM THERAPEUTICS PLC | $517,000 | -9.5% | 1,456,303 | 0.0% | 0.26% | +23.2% | |
| AVRO | AVROBIO INC | $417,000 | -65.7% | 315,550 | 0.0% | 0.21% | -53.2% | |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $254,000 | -19.4% | 50,000 | 0.0% | 0.12% | +9.6% | |
| OBSV | Exit | OBSEVA SA | $0 | – | -900,501 | -100.0% | -0.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.